Rac1 mediates STAT3 activation by autocrine IL-6

T R Faruqi1, D Gomez, X R Bustelo

  • 1Department of Pathology, State University of New York, Stony Brook, NY 11794, USA.

Insights

The small GTPase Rac1 activates signal transducer and activator of transcription 3 (STAT3) signaling. Rac1 induces STAT3 activation indirectly via an autocrine interleukin-6 (IL-6) loop, linking oncogenic GTPase activity to JAK/STAT signaling.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Oncology

Background:

  • The small GTPase Rac1 is crucial for cellular processes like cytoskeletal rearrangement, gene transcription, and malignant transformation.
  • Signal transducers and activators of transcription (STATs), particularly STAT3, are key mediators in cellular signaling pathways.
  • Dysregulation of Rac1 and STAT3 signaling is implicated in various cancers.

Purpose of the Study:

  • To investigate the mechanism by which constitutively active Rac1 (Rac V12) influences STAT3 activation.
  • To elucidate the role of autocrine signaling and specific molecular players in Rac1-mediated STAT3 activation.
  • To establish a link between oncogenic GTPase activity and the Janus kinase/STAT signaling pathway.

Main Methods:

  • Utilized constitutively active Rac1 (Rac V12) and Vav (Delta1-187) expression systems.
  • Assessed STAT3 activation through translocation, gene expression, and tyrosine phosphorylation at residue 705.
  • Employed neutralizing antibodies against IL-6 receptor, and expression of IkappaBalpha S32AS36A and suppressor of cytokine signaling 3 to inhibit signaling pathways.

Main Results:

  • Constitutively active Rac1 (Rac V12) stimulates STAT3 activation, leading to nuclear translocation and STAT3-dependent gene expression.
  • Rac1-induced STAT3 activation is mediated indirectly through the autocrine production and action of IL-6.
  • Rac V12 expression upregulates IL-6 and IL-6 receptor genes; inhibition of IL-6 signaling or nuclear factor-kappaB blocks Rac1-induced STAT3 activation.

Conclusions:

  • Rac1 activates STAT3 through an autocrine IL-6 signaling loop, involving IL-6 and IL-6 receptor gene induction.
  • The mechanism requires tyrosine phosphorylation of STAT3 at residue 705 and is dependent on nuclear factor-kappaB activation.
  • This study establishes a novel link between oncogenic GTPase activity (Rac1) and the JAK/STAT signaling pathway via IL-6.

Related Concept Videos

Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...